PMS-ENTECAVIR DIN 02430584
Health Canada record
| Active ingredient(s) | ENTECAVIR 1 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J05AF10 ENTECAVIR |
| Original market date | 10-Sep-2014 |
| Current status date | 02-Sep-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pharmascience Inc. — licence 100241, currently licensed, last inspection rating C (2025-03-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ENTECAVIR
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02396955 | APO-ENTECAVIR | APOTEX INC | Tablet | ENTECAVIR 0.5 MG | Marketed |
| 02282224 | BARACLUDE | BRISTOL-MYERS SQUIBB CANADA | Tablet | ENTECAVIR 0.5 MG | Marketed |
| 02527154 | ENTECAVIR | SANIS HEALTH INC | Tablet | ENTECAVIR 0.5 MG | Marketed |
| 02527162 | ENTECAVIR | SANIS HEALTH INC | Tablet | ENTECAVIR 1 MG | Approved |
| 02430576 | PMS-ENTECAVIR | PHARMASCIENCE INC | Tablet | ENTECAVIR 0.5 MG | Marketed |
| 02418312 | SANDOZ ENTECAVIR | SANDOZ CANADA INCORPORATED | Tablet | ENTECAVIR 0.5 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 15990 | 2014-08-26 | Abbreviated New Drug Submission (ANDS) |
International API supply for ENTECAVIR
14 active FDA Drug Master Files.
Request a quote for PMS-ENTECAVIR